Search

Search Constraints

You searched for: Author/Creator Inusa, Baba

Search Results

1. 13‐valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6‐17 years of age with sickle cell disease previously vaccinated with 23‐valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study. Issue 8 (23rd March 2015)

2. 13‐valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6‐17 years of age with sickle cell disease previously vaccinated with 23‐valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study. Issue 8 (23rd March 2015)

7. Clinical management of sickle cell liver disease in children and young adults. Issue 4 (11th November 2020)

10. Differences in lung function between children with sickle cell anaemia from West Africa and Europe. Issue 12 (17th October 2019)